| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.098 | 0.04 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.062 | 0.05 |